VCYT250117C40000
- 0.80
- -1.70-68.00%
Veracyte Newsroom
Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 39% Discount?
Should You Consider Retaining ZBH Stock in Your Portfolio Now?
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says
Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability
HOLX Stock Gains Following the Acquisition of Gynesonics
Insider Sale: Director at $VCYT (VCYT) Sells 5,309 Shares
Veracyte Gains 44% in a Year: What's Driving the Stock?
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
Breakeven Is Near for Veracyte, Inc. (NASDAQ:VCYT)
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
Express News | Veracyte Inc : Guggenheim Raises Target Price to $45 From $40
Those Who Invested in Veracyte (NASDAQ:VCYT) a Year Ago Are up 68%
If You Invested $1000 in Veracyte a Decade Ago, This Is How Much It'd Be Worth Now
Express News | Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in Nccn® Prostate Cancer Guidelines
Veracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN Prostate Cancer Guidelines
Goldman Sachs Downgrades Veracyte(VCYT.US) to Hold Rating
Goldman Sachs Downgrades Veracyte to Neutral, Lowers Price Target to $37
Insider Sale: VP of $VCYT (VCYT) Sells 5,032 Shares